Early Alzheimer's disease neuropathology detected by proton MR spectroscopy. - Wikidata - awgldk - TriplyDB

Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.

Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.

http://www.wikidata.org/entity/Q34614543

about

Preclinical Magnetic Resonance Imaging and Spectroscopy Studies of Memory, Aging, and Cognitive Decline Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's Disease Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression.Probing astrocyte metabolism in vivo: proton magnetic resonance spectroscopy in the injured and aging brain Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using 18F-FDG-PET.Test-retest reproducibility of neurochemical profiles with short-echo, single-voxel MR spectroscopy at 3T and 7T APOE genotype and age modifies the correlation between cognitive status and metabolites from hippocampus by a 2D (1)H-MRS in non-demented elders Magnetic Resonance Spectroscopy discriminates the response to microglial stimulation of wild type and Alzheimer's disease models.Hitchhiker's Guide to Voxel Segmentation for Partial Volume Correction of In Vivo Magnetic Resonance Spectroscopy.Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.Advances in Neuroimaging for Neurodegenerative Disease.A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ4 Mexico City Children and Their Parents.1H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults.Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with 1H-MRS and Pittsburgh Compound-B PET.Covertly active and progressing neurochemical abnormalities in suppressed HIV infection.Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases.Cognitive impairment in progressive supranuclear palsy is associated with tau burden.Astrocyte and Alzheimer's disease.Longitudinal investigation of neuroinflammation and metabolite profiles in the APPswe ×PS1Δe9 transgenic mouse model of Alzheimer's disease.Ultra-High Field Proton MR Spectroscopy in Early-Stage Amyotrophic Lateral Sclerosis.Translocator positron-emission tomography and magnetic resonance spectroscopic imaging of brain glial cell activation in multiple sclerosis.Magnetic resonance spectroscopy reveals abnormalities of glucose metabolism in the Alzheimer's brain.Dynamic metabolic patterns tracking neurodegeneration and gliosis following 26S proteasome dysfunction in mouse forebrain neurons.Lower Choline and Myo-Inositol in Temporo-Parietal Cortex Is Associated With Apathy in Amnestic MCI.Poly-GR dipeptide repeat polymers correlate with neurodegeneration and Clinicopathological subtypes in C9ORF72-related brain disease

P2860

Q26741139-A4CE3B22-061C-40A6-8E28-C5A22DF486BA Q26744646-C9BE8729-500A-42A9-80E7-6E95ED6B865E Q27301267-23F73ABF-8135-46DB-8D66-C5FA5A67275B Q31025300-39B49592-FE08-4D0D-8984-2B40B2DCCC58 Q31138018-727BA2F0-EE40-4BD6-B9FB-956B92562C71 Q35821532-8FCFE357-E2D9-47EC-8878-A8739D6C128C Q36083501-A2100A45-AA08-49BA-B2F3-40FCA418DE03 Q36507045-21FD2626-43B0-4C58-BFA7-707B0688040F Q36848247-FE8E55AA-FA57-4C6A-94FA-E2EF86A54129 Q36887148-D9247422-C9F3-42CD-8964-B006B1333456 Q38461098-5BE13010-F13F-43D8-9490-62C35001FACC Q38663083-C85756C3-9150-4770-A70B-BD3223D124DD Q40316451-C6129AC3-5643-425A-97E2-17F70FE6809E Q42665050-A6EA3622-11B5-4B3C-A89E-DD355DA8F57F Q44793917-D1789A40-CBC5-4E9B-8052-4FA49E0B24F8 Q47193060-ECF4BEF5-F407-4C78-9898-9B42DA16BECD Q47651485-E0CD0EA4-F31B-470F-BEDF-CF7EEE71E1AB Q47995402-C1207EDD-45CE-428B-AE24-76F14B1772CD Q48148540-B4742541-A002-442D-B29A-FE464B0AD17F Q48327909-0602D353-A92E-4032-A695-37F49221498D Q48337962-1CC4A4AB-A6EA-4161-8D0C-B1618C76748A Q48411197-C2F111A5-60AD-4509-BE52-4C76AA0D9470 Q51761053-732C5152-5127-40CB-9770-7B48518196F0 Q52725603-CC86D85F-6417-4B23-89E7-9ECD422D6CDE Q54969837-26E32AAA-334C-4EB7-9732-D6A076E60B70 Q57306318-E74C98CF-2821-41AC-9F03-5B12C8813292

P2860

Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.

http://www.wikidata.org/entity/Q34614543

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.

@ast

Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.

@en

Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.

@nl

type

label

Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.

@ast

Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.

@en

Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.

@nl

prefLabel

Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.

@ast

Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.

@en

Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.

@nl

P1433

Q34614543-6C5348C6-AEA8-4C69-BBB7-497DB3E3DB66

P1476

Q34614543-284C2AEE-0C9E-41F1-B8B7-35AB323A4642

P2093

Q34614543-324BF72E-68AE-4AC6-AD74-71F070D2B5F3

Q34614543-3633C18F-F33F-40DA-A01C-D432880B6F63

Q34614543-3EE46CEB-32AC-49B5-85D3-4F114E83B761

Q34614543-7893631B-9531-451A-BFD4-D13ECAE0E0E1

Q34614543-925A8110-BEFF-4B36-8175-EA6518BC4C7C

Q34614543-952D9EF7-CE79-4BEF-BA9D-69104F1DF149

Q34614543-A91ECD10-AB5F-427E-88A1-FF5C603CC42F

Q34614543-BE833CE0-5AEF-460F-B7D7-8EDC66C34C24

Q34614543-C95D767A-7A30-431E-8EDE-AF69772B949B

P2860

Q34614543-01CA876D-F285-43EA-B841-7E19D8170358

Q34614543-0270CF30-068F-4D1A-A146-0966A915E0A8

Q34614543-06AEEAE9-9D91-48CE-A34E-BA09135C4AFC

Q34614543-0AFE5ECA-385E-4C6D-947E-1BCDBCAB7008

Q34614543-12446289-944D-4009-826F-4FA22D9ADA83

Q34614543-1627ED97-8DBD-4428-A890-F5217512044D

Q34614543-209E81A7-D472-442A-B8C5-D51448075B8F

Q34614543-2174C799-F58B-4C99-9C65-6E4ECC47034A

Q34614543-26DB8C27-F761-4CC9-8F78-52672A31EB13

Q34614543-35B03121-2B90-409B-99AE-9657DE17BE1E

P304

Q34614543-46EA7B73-0753-4B95-9626-898E9FED51D0

P31

Q34614543-16548E59-C9B1-4A3D-B1BC-F541134B0367

P356

Q34614543-A9D84BD6-B08C-4E6F-8B30-2A1DEA86119F

P407

Q34614543-78AB16C5-DB84-43E4-B9CD-A59D6AC31073

P433

Q34614543-2E80345E-D82F-454A-BC45-D9A479FC838F

P478

Q34614543-2DB61211-A924-4BC7-BC75-32C6A70852B1

P50

Q34614543-5D871678-05E1-40F4-9839-AD12F9A81BCA

Q34614543-A5CF54C4-BCBA-4242-B37B-4FD17134DD46

Q34614543-BB7F370F-F202-493C-85C2-C9689B3068DF

Q34614543-DFCD70BB-3512-4B21-B182-69FD4FCA884D

Q34614543-DFEB7B35-F18C-4477-8F45-2BD34C13E6A1

P577

Q34614543-12A68CFB-7A38-4AFB-B07F-3267863662F1

P698

Q34614543-8D345D81-B34E-49B6-8E0F-B0ABE928639B

P921

Q34614543-BB9938F4-F69B-480B-B17D-48EA4C65DDF2

P932

Q34614543-A397C6BE-BD9A-43A3-A8D6-26A74D9AD2D2

P356

JNEUROSCI.2027-14.2014

P1433

Journal of Neuroscience

P1476

Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.

@en

P2093

Amanda M Liesinger

http://www.w3.org/2001/XMLSchema#string

Anthony Spychalla

http://www.w3.org/2001/XMLSchema#string

Bing Zhang

http://www.w3.org/2001/XMLSchema#string

Bradley F Boeve

http://www.w3.org/2001/XMLSchema#string

Dennis W Dickson

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Gunter

http://www.w3.org/2001/XMLSchema#string

Joseph E Parisi

http://www.w3.org/2001/XMLSchema#string

Scott A Przybelski

http://www.w3.org/2001/XMLSchema#string

Timothy G Lesnick

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

Neuropathological stageing of Alzheimer-related changes

No adjustments are needed for multiple comparisons

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

What's wrong with Bonferroni adjustments.

Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids.

P304

16247-16255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1523/JNEUROSCI.2027-14.2014

http://www.w3.org/2001/XMLSchema#string

P407

P433

49

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Melissa E. Murray

Ronald C. Petersen

David S Knopman

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25471565

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4252542

http://www.w3.org/2001/XMLSchema#string